# FDA Inspection 1157813 - Edge Pharma, LLC - November 30, 2021

Source: https://www.keypedia.com/records/fda_inspections/edge-pharma-llc/81abe56f-7f3d-4386-a02b-60f140ce309b
Source feed: FDA_Inspections

> FDA Inspection 1157813 for Edge Pharma, LLC on November 30, 2021. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1157813
- Company Name: Edge Pharma, LLC
- Inspection Date: 2021-11-30
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1043506 - 2018-03-08](https://www.keypedia.com/records/fda_inspections/edge-pharma-llc/4d7f95a2-7394-47d5-b1a8-7901ab1976b8)
- [FDA Inspection 1001351 - 2017-01-20](https://www.keypedia.com/records/fda_inspections/edge-pharma-llc/65d0bc78-7576-43f8-8c66-997c12ec054f)
- [FDA Inspection 893817 - 2014-08-20](https://www.keypedia.com/records/fda_inspections/edge-pharma-llc/6a4e8ccc-a7e7-4110-b31d-38523964be4e)

Company: https://www.keypedia.com/companies/edge-pharma-llc/8e1a2d92-d72f-4102-8b1a-e37e96a75b69

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c